Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Viruses (33)
- Medical Specialties (30)
- Public Health (27)
- Infectious Disease (24)
- Diseases (21)
-
- Community Health and Preventive Medicine (18)
- International Public Health (18)
- Pulmonology (18)
- Virus Diseases (18)
- Epidemiology (17)
- Internal Medicine (17)
- Respiratory Tract Diseases (17)
- Health Information Technology (15)
- Nursing (15)
- Bacteria (14)
- Translational Medical Research (14)
- Bacterial Infections and Mycoses (13)
- Public Health and Community Nursing (13)
- Critical Care Nursing (12)
- Influenza Humans (12)
- Sleep Medicine (10)
- Life Sciences (6)
- Patient Safety (4)
- Immunology and Infectious Disease (3)
- Medical Sciences (3)
- Social and Behavioral Sciences (3)
- Chemicals and Drugs (2)
- Clinical Epidemiology (2)
- Institution
- Publication
-
- The University of Louisville Journal of Respiratory Infections (17)
- Department of Paediatrics and Child Health (3)
- Medical College Documents (3)
- All Faculty Scholarship (1)
- Department of Emergency Medicine (1)
-
- Department of Pathology and Laboratory Medicine (1)
- Department of Psychiatry (1)
- Department of Surgery (1)
- Electronic Thesis and Dissertation Repository (1)
- HCA Healthcare Journal of Medicine (1)
- MEDI 9331 Scholarly Activities Clinical Years (1)
- Section of Diabetes, Endocrinology and Metabolism (1)
- Section of Pulmonary & Critical Care (1)
- St. Mary's Law Journal (1)
- Woman and Child Health (1)
- Publication Type
Articles 31 - 35 of 35
Full-Text Articles in Organisms
Epidemiology And Outcomes Of Hospitalized Adults With Sars-Cov-2 Community-Acquired Pneumonia In Louisville, Kentucky, Julio A. Ramirez, T'Shura Ali, Thomas Chandler, Stephen P. Furmanek, Daniya Sheikh, Vidyulata Salunkhe, Steven Gootee, Mohammad Tahboub, William A. Mattingly, Demetra Antimisiaris, Jiapeng Huang, Jose Bordon, Rodrigo Cavallazzi, Paul Schulz, William P. Mckinney, Dawn Balcom, Mark Burns, Ruth Carrico, Forest W. Arnold, Cerid Covid-19 Study Group
Epidemiology And Outcomes Of Hospitalized Adults With Sars-Cov-2 Community-Acquired Pneumonia In Louisville, Kentucky, Julio A. Ramirez, T'Shura Ali, Thomas Chandler, Stephen P. Furmanek, Daniya Sheikh, Vidyulata Salunkhe, Steven Gootee, Mohammad Tahboub, William A. Mattingly, Demetra Antimisiaris, Jiapeng Huang, Jose Bordon, Rodrigo Cavallazzi, Paul Schulz, William P. Mckinney, Dawn Balcom, Mark Burns, Ruth Carrico, Forest W. Arnold, Cerid Covid-19 Study Group
The University of Louisville Journal of Respiratory Infections
Background: During the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), SARS-CoV-2 community-acquired pneumonia (CAP) has been the primary cause of hospitalization. The objective of this study was to evaluate the clinical characteristics and outcomes of 1,013 patients hospitalized with SARS-CoV-2 CAP from September 2020 through March 2021 in Louisville, Kentucky.
Methods: This was a retrospective observational study of 1,013 patients hospitalized with SARS-CoV-2 CAP at eight of the adult hospitals in the city of Louisville from September 2020 through March 2021. Patients with 1) a positive reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV-2, 2) fever, cough, or …
Covid-19: Race For Vaccine, L. Hayley Burgess, Jason J. Braithwaite, Emily Singleton, Aaron M. Young, Mandelin K. Cooper
Covid-19: Race For Vaccine, L. Hayley Burgess, Jason J. Braithwaite, Emily Singleton, Aaron M. Young, Mandelin K. Cooper
HCA Healthcare Journal of Medicine
The world is in the midst of a pandemic from COVID-19, a disease caused by the virus SARS-CoV-2. Despite broad mitigation efforts, new cases continue with 74 million cases and 1.6 million deaths worldwide. Regardless of previous research efforts, there is no commercially available vaccine for any coronavirus. Novel vaccine development has historically taken at least 10 years from discovery to availability with only a 6% market entry probability.
With the global impact, there is an urgency to expedite a vaccine to protect the population. The U.S. government launched Operation Warp Speed with the goal to produce and deliver 300 …
Vitamin D In Covid-19 Pneumonia: High Yield With Low Risk, Shahan Waheed, Emaduddin Siddiqui
Vitamin D In Covid-19 Pneumonia: High Yield With Low Risk, Shahan Waheed, Emaduddin Siddiqui
Department of Emergency Medicine
No abstract provided.
How Immune T-Cell Augmentation Can Help Prevent Covid-19: A Possible Nutritional Solution Using Ketogenic Lifestyle, Ravi K. Kamepalli Md,Fidsa,Cwsp
How Immune T-Cell Augmentation Can Help Prevent Covid-19: A Possible Nutritional Solution Using Ketogenic Lifestyle, Ravi K. Kamepalli Md,Fidsa,Cwsp
The University of Louisville Journal of Respiratory Infections
No abstract provided.
Mapping Misinformation In The Coronavirus Outbreak, Ana Santos Rutschman
Mapping Misinformation In The Coronavirus Outbreak, Ana Santos Rutschman
All Faculty Scholarship
The coronavirus outbreak has sent ripples of fear and confusion across the world. These sentiments—and our collective responses to the outbreak—are made worse by rampant misinformation surrounding the new strain of the virus, COVID-2019. In this post, I survey some of the most pervasive areas of tentacular coronavirus-related misinformation that has proliferated online -- as well as the responses of social media companies like YouTube, Facebook, Pinterest and TikTok that may ultimately prove inadequate given the magnitude of the problem.